This inventor holds 2 USPTO granted patents. Top assignees: Ono Pharmaceutical Co., Ltd., Vanderbilt University. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 575 
2 out of 1,221 
Years Active: 2021-2023
Title: Yoko Sekioka: Innovator in TREK Channel Activation
Introduction
Yoko Sekioka is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of biochemistry, particularly in the activation of TREK (TWIK Related Kchannels) channels. With a total of two patents to her name, Sekioka's work has garnered attention in both academic and pharmaceutical circles.
Latest Patents
Sekioka's latest patents include a compound of formula (I) that serves as an activator of TREK channels. This innovative compound has the potential to advance the understanding and treatment of various physiological conditions related to potassium channels.
Career Highlights
Throughout her career, Sekioka has worked with notable organizations, including Ono Pharmaceutical Co., Ltd. and Vanderbilt University. Her experience in these institutions has allowed her to develop her research and contribute to significant advancements in her field.
Collaborations
Sekioka has collaborated with esteemed colleagues such as Craig William Lindsley and Joshua M Wieting. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Yoko Sekioka's contributions to the activation of TREK channels highlight her innovative spirit and dedication to advancing scientific knowledge. Her work continues to inspire future research in the field of biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile